PharmaTher Holdings Ltd. — Investor Relations & Filings
PharmaTher Holdings Ltd. is a specialty pharmaceutical company dedicated to the research, development, and commercialization of novel therapeutics, primarily focusing on ketamine and psychedelic compounds. The company's strategy involves advancing three core assets: the KETARX™ portfolio of ketamine drugs, which targets neuropsychiatric and pain disorders; the proprietary PharmaPatch™ microneedle patch platform, designed for the transdermal delivery of ketamine, psychedelics, and GLP-1 drugs; and a 49% ownership interest in Sairiyo Therapeutics Inc., which is developing a patented oral formulation of cepharanthine for infectious diseases and cancer. PharmaTher is focused on achieving regulatory approval for its pipeline candidates to address significant global unmet medical needs in mental health, neurological, and pain disorders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Documents affecting rights of securityholders (or amendment thereto).PDF | 2020-07-23 | English | |
| Documents affecting rights of securityholders (or amendment thereto).PDF | 2020-07-23 | English | |
| Documents affecting rights of securityholders (or amendment thereto).PDF | 2020-07-23 | English | |
| Other material contract(s).PDF | 2020-07-23 | English | |
| Preliminary long form prospectus - English.PDF | 2020-07-23 | English | |
| Report of exempt distribution excluding schedule 1 of Form 5.pdf | 2020-07-20 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
8 filings
| |||||
| 13422781 | Documents affecting rights of securityholders (or amendment thereto).PDF | 2020-07-23 | English | ||
| 13422779 | Documents affecting rights of securityholders (or amendment thereto).PDF | 2020-07-23 | English | ||
| 13422778 | Documents affecting rights of securityholders (or amendment thereto).PDF | 2020-07-23 | English | ||
| 13422776 | Other material contract(s).PDF | 2020-07-23 | English | ||
| 13422775 | Preliminary long form prospectus - English.PDF | 2020-07-23 | English | ||
| 47775253 | Report of exempt distribution excluding schedule 1 of Form 5.pdf | 2020-07-20 | English | ||
| 47775261 | Report of exempt distribution excluding schedule 1 of Form 5 (amended).pdf | 2020-02-10 | English | ||
| 13394121 | Report of exempt distribution excluding schedule 1 of Form 5.pdf | 2020-02-06 | English | ||
|
2019
1 filing
| |||||
| 47775264 | Report of exempt distribution excluding schedule 1 of Form 5.pdf | 2019-12-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaTher Holdings Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47881/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47881 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47881 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47881 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47881}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaTher Holdings Ltd. (id: 47881)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.